Philippines approves GMO golden rice for commercial production
By Staff,
GMWatch
| 07. 23. 2021
No independent health risk assessment was done; Farmer-scientist group MASIPAG condemns decision
The Philippines has approved GMO golden rice for commercial production. This is in spite of the fact that no independent data on the safety of this GMO for health and the environment have been published; that beta-carotene, which the rice is engineered to contain, is one of the commonest molecules in nature and numerous native plants contain high levels; and that the US FDA says that GMO golden rice doesn't contain enough beta-carotene to justify a health claim.
As Glenn Davis Stone and Dominic Glover point out, it is still unknown if the beta-carotene in GMO golden rice can even be converted to Vitamin A in the bodies of badly undernourished children. In addition, research shows that what beta-carotene there is in the rice degrades rapidly in storage. Cooking further degrades the beta-carotene.
Meanwhile, as the development of golden rice creeps along, the Philippines has managed to slash the incidence of Vitamin A deficiency by non-GMO methods.
The author of the France24 article below is clearly ignorant of these crucial facts.
1. Philippines approves GMO 'golden rice'...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...